MIRIAM DINEEN: Open Payments
NPI 1164651956 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 30 payments from 10 companies in 2025. Trend: 2023 $10,537 · 2024 $591 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $290 |
| ABBVIE INC. | 6 | $225 |
| Vanda Pharmaceuticals Inc. | 6 | $195 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $80 |
| E.R. Squibb & Sons, L.L.C. | 1 | $62 |
| Lundbeck LLC | 2 | $41 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
Products named: VRAYLAR, FANAPT, REXULTI, ARISTADA, LYBALVI, Sunosi, COBENFY, DUPIXENT.
Industry payments across NC — which companies pay providers there.
